1 / 73

Vanderbilt’s DNA Databank : BioVU

Vanderbilt’s DNA Databank : BioVU. Personalized Medicine. Integration of genomic information into clinical decision making Personalized disease treatment and also preventative therapies. What is BioVU ?.

evania
Télécharger la présentation

Vanderbilt’s DNA Databank : BioVU

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Vanderbilt’s DNA Databank: BioVU

  2. Personalized Medicine • Integration of genomic information into clinical decision making • Personalized disease treatment and also preventative therapies

  3. What is BioVU? • The move towards personalized medicine requires very large sample sets for discovery and validation • BioVU: biobank intended to support a broad view of biology and enable personalized medicine • Contains de-identified DNA extracted from leftover blood after clinically-indicated testing of Vanderbilt patients who have not opted out • Linked to Synthetic Derivative: de-identified EMR • Current sample number: 135,765 • 120,705 adult samples • 15,099 pediatric samples

  4. Patient Communication Modules

  5. Extract DNA John Doe A7CCF99DE65732…. eligible A7CCF99DE5732…. One way hash scrubbed A7CCF99DE65732…. John Doe The “synthetic derivative” (SD): can be updated

  6. The Synthetic Derivative • A Derivative of the EMR - information content reduced by ‘scrubbing’ identifiers • Systematically shifted event dates • Contains ~1.9 million records • ~1 million with detailed longitudinal data • averaging 100,000 bytes in size • an average of 27 codes per record • Records updated over time and are current through 4/30/11

  7. Synthetic Derivative Data Types • Narratives, such as: • Clinical Notes • Discharge Summaries • History and Physicals • Problem Lists • Surgical Reports • Progress Notes • Letters • Diagnostic Codes, Procedural Codes • Forms (intake, assessment) • Reports (pathology, ECGs, echocardiograms) • Clinical Communications • Lab Values and Vital Signs • Medication Orders • TraceMaster (ECGs)

  8. Synthetic Derivative vs. BioVU A7CDE6532…. + scrubbed scrubbed A7CDE6532 …. A7CDE6532 …. Synthetic Derivative BioVU ~1.9 million ~135,000

  9. Sample accrual Current accrual as of 2-13-2012: 135,765 samples 15,099 pediatric

  10. BioVU Demographics AGE GENDER RACE

  11. BioVU Sample Management RTS SmaRTStore

  12. Validation in BioVU • Sample handling algorithms • Gender match • 1/384 gender mismatches • Ancestry • Characterize sample ancestry, assess usefulness of ‘race’ as defined in EMR • Provide a panel of ancestry informative markers that define ancestry • No significant difference between the concordance of self-report or observer-report with genetic ancestry • Demonstration project – American Journal of Human Genetics, 2010 • Can known associations between genetic variants and common diseases be identified in the EMR?

  13. The “demonstration project” Genotype “high-value” SNPs in the first 8,000 samples accrued. including SNPs associated by replicated genome-wide experiments with common diseases & traits Atrial fibrillation Crohn’s disease Multiple Sclerosis Rheumatoid arthritis Type II Diabetes Develop Natural Language Processing methods to identify cases and controls Are genotype-phenotype relations replicated?

  14. First results gene / disease marker region rs2200733 Chr. 4q25 Atrial fibrillation rs10033464 Chr. 4q25 rs11805303 IL23R rs17234657 Chr. 5 Crohn's disease rs1000113 Chr. 5 rs17221417 NOD2 rs2542151 PTPN22 rs3135388 DRB1*1501 Multiple sclerosis rs2104286 IL2RA rs6897932 IL7RA rs6457617 Chr. 6 Rheumatoid arthritis rs6679677 RSBN1 rs2476601 PTPN22 rs4506565 TCF7L2 rs12255372 TCF7L2 rs12243326 TCF7L2 rs10811661 CDKN2B Type 2 diabetes rs8050136 FTO rs5219 KCNJ11 rs5215 KCNJ11 rs4402960 IGF2BP2 0.5 1.0 5.0 2.0 Odds Ratio

  15. First results gene / disease marker region rs2200733 Chr. 4q25 Atrial fibrillation rs10033464 Chr. 4q25 rs11805303 IL23R rs17234657 Chr. 5 Crohn's disease rs1000113 Chr. 5 rs17221417 NOD2 rs2542151 PTPN22 rs3135388 DRB1*1501 Multiple sclerosis rs2104286 IL2RA rs6897932 IL7RA rs6457617 Chr. 6 Rheumatoid arthritis rs6679677 RSBN1 rs2476601 PTPN22 rs4506565 TCF7L2 rs12255372 TCF7L2 rs12243326 TCF7L2 rs10811661 CDKN2B Type 2 diabetes rs8050136 FTO rs5219 KCNJ11 rs5215 KCNJ11 rs4402960 IGF2BP2 0.5 1.0 5.0 2.0 Odds Ratio

  16. Types of projects • Discovery or validation of genotype-phenotype relations for disease susceptibility or drug responses • Discovery of new disease/susceptibility genes  resequence in patients (obesity, Cushing's, susceptibility to infection, insomnia, pre-term birth) • Access samples without disease X, or “normals” of specified ancestry, or old normals • Phenome-wide association study (PheWAS): in development

  17. Data Use Agreement

  18. Genotyping Data Accrual

  19. Common Diagnoses in BioVU

  20. Examples of ICD-9 codes for rare diseases

  21. Not included in SD searches: • Bone marrow transplant • SCID • Flagged Compromised samples: • Transfusion within 2 weeks of blood draw • Leukemia • Myeloma • Lymphoma • Pre-leukemic states

More Related